Foltys, D; Heise, M; Hoppe-Lotichius, M et al.
SURGERY OF HEPATOCELLULAR CARCINOMA IN CIRRHOSIS: LIVER RESECTION VERSUS LIVER TRANSPLANTATIONTRANSPLANT INTERNATIONAL. Bd. 24. 2011 S. 3-3
Wurschmidt, F; Riesenbeck, D; Zuhlke, H et al.
Surgical Complications after neoadjuvant Chemotadiotherapy with CAPOX plus Bevacizumab in locally advanced Rectal CancerSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 187. 2011 S. 30-30
Niederle, IM; Woerns, MA; Koch, S et al.
SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) IN RELATION TO THE MELD SCORE AT INITIAL DIAGNOSIS IN A WESTERN COHORT WITH 680 PATIENTSHEPATOLOGY. Bd. 54. 2011 S. 1386A-1386A
Pol, S; Berg, T; Bonacini, M et al.
SVR AND PHARMACOKINETICS OF THE HCV PROTEASE INHIBITOR BI201335 WITH PEGIFN/RBV IN HCV GENOTYPE-1 PATIENTS WITH COMPENSATED LIVER CIRRHOSIS AND NON-RESPONSE TO PREVIOUS PEGIFN/RBVJOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S486-S486
Weng, SY; Yang, CY; Li, CC et al.
Synergism between p53 and Mcl-1 in protecting from hepatic injury, fibrosis and cancerJOURNAL OF HEPATOLOGY. Bd. 54. H. 4. 2011 S. 685-694
Otto, G; Schuchmann, M; Hoppe-Lotichius, M et al.
TACE BEFORE LIVER TRANSPLANTATION: RESPONSE TO BRIDGING PREDICTS HCC RECURRENCETRANSPLANT INTERNATIONAL. Bd. 24. 2011 S. 141-141
Pitton, MB; Skowasch, M; Schneider, J et al.
TACE beim HCC im Stadium BCLC-B und –c: DC Bead-TACE versus konventionelle TACEFortschr Röntgenstr. Bd. 183. H. S1. 2011 S. S181
Poelstra, K; Schuppan, D
Targeted therapy of liver fibrosis/cirrhosis and its complicationsJOURNAL OF HEPATOLOGY. Bd. 55. H. 3. 2011 S. 726-728
Menke, J; Bork, T; Kutska, B et al.
Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in miceKIDNEY INTERNATIONAL. Bd. 79. H. 4. 2011 S. 452-463
Foltys, DB; Kaths, JM; Zimmermann, T et al.
Ten Years of Simultaneous Pancreas-Kidney Transplantation: A Retrospective Single-Center Analysis of Prospectively Obtained DataTRANSPLANTATION PROCEEDINGS. Bd. 43. H. 9. 2011 S. 3267-3269